Clin2
NCT06487533Possibly a fitRecruiting

Sensing opioid withdrawal and cravings with wearable sensors

Opioid WithdrawalOpioid Use Disorder

Part of Mental health clinical trials.

This study uses wearable sensors to track physical signs of opioid withdrawal and cravings over 14 days. It aims to better understand these symptoms in people currently taking or planning to start medication for opioid use disorder.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years to 50 years
Study type
Observational

Who can take part

  • Had recent opioid dependence (prescription or not)
  • Currently taking or planning to start medication for opioid use disorder (MOUD)
  • Between 18 and 50 years old
  • Fluent in English
  • No uncontrolled medical or psychiatric condition, history of seizures, or recent suicidal thoughts

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07079215Recruiting
Device trial for opioid withdrawal symptoms

This trial tests a physical device (ADTPM 1) to help manage withdrawal symptoms in people who are dependent on opioids. The goal is to see if the device can safely reduce withdrawal discomfort.

Daegu, Daegu
NCT07094672Not yet recruiting
Measuring opioid withdrawal symptoms

This study is developing a questionnaire to better measure opioid withdrawal symptoms. By participating, you'll help create a tool that may improve how withdrawal is assessed in future care and research.

Baltimore, Maryland
NCT05027919Recruiting· Phase 2
Testing ways to predict opioid withdrawal during a taper

This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.

Baltimore, Maryland
NCT05033028Recruiting· Phase 3
Using a smartphone to support opioid addiction recovery

This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.

Piscataway, New Jersey
NCT05829655Recruiting· Early Phase 1
Measuring drug cravings in people with opioid use disorder

This study tests whether the medication suvorexant can reduce drug cravings in people with opioid use disorder. You will take either suvorexant or a placebo and have your cravings measured in a safe setting.

Baltimore, Maryland
NCT06643988Recruiting
Memory and thinking study for opioid use disorder

This study looks at how people with opioid use disorder remember personal events. You'll do tasks on a cellphone and at home while taking medication for opioid use disorder.

Philadelphia, Pennsylvania

Hear when a new Opioid Withdrawal trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.